2016-03-21 19:05:33 UTC

Gut Microbiota Imbalance Harms Liver

March 22, 2016

Hepatologists should review this fact sheet for an overview of the role of the gut microbiome in liver diseases.

The potential consequences of gut microbial dysbiosis are not restricted to bowel conditions. At the 2016 Gut Microbiota for Health World Summit earlier this month, Bernd G. Schnabl, MD, from the University of California, San Diego, presented on the role of the gut microbiome in liver diseases.

You can read an overview of Dr. Schnabl’s presentation in this fact sheet from the meeting. The fact sheet explains why diseases such as NAFLD, NASH, alcoholic liver disease and cirrhosis are associated with a disturbed microbial balance in the intestines, and explains the mechanisms behind the onset of these diseases.

More Microbiome Updates
Last week we shared information from the summit on the gut microbiome as a new kind of biomarker for GI diseases. Check out other fact sheets from the summit, as well as videos and infographics, by visiting the conference website.

Learn more about the gut microbiome by visiting the AGA Center for Gut Microbiome Research and Education.

More on Cirrhosis

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.

Spotlight on Fellow-Led Quality Improvement Projects

Oct. 3, 2017

These 19 projects presented at DDW® 2017 showcase the extensive work being done by fellows to improve the quality of care provided to GI patients.

Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents

Oct. 1, 2017

Among HCV-infected patients treated with DAAs, SVR is associated with a considerable reduction in the risk of HCC; however, the risk for HCC remained high in patients with cirrhosis at the time of SVR.